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In Brief
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of neurodevelopment. Tanabe et al. show
that torsinA-related nuclear membrane
budding similarly occurs during a critical
period of CNS maturation and identify
torsinB as a factor that modulates and
can rescue this process.
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DYT1 dystonia is a neurodevelopmental disease that
manifests during a discrete period of childhood. The
disease is caused by impaired function of torsinA,
a protein linked to nuclear membrane budding. The
relationship of NE budding to neural development
and CNS function is unclear, however, obscuring
its potential role in dystonia pathogenesis. We find
NE budding begins and resolves during a discrete
neurodevelopmental window in torsinA null neurons
in vivo. The developmental resolution of NE budding
corresponds to increased torsinB protein, while
ablating torsinB from torsinA null neurons prevents
budding resolution and causes lethal neural dysfunc-
tion. Developmental changes in torsinB also corre-
late with NE bud formation in differentiating DYT1
embryonic stem cells, and overexpression of torsinA
or torsinB rescues NE bud formation in this system.
These findings identify a torsinA neurodevelopmen-
tal window that is essential for normal CNS function
and have important implications for dystonia patho-
genesis and therapeutics.
INTRODUCTION
An important challenge to unraveling the pathogenesis of in-
herited neurodevelopmental diseases is determining whether
pathogenic proteins play unique roles during CNS development
(e.g., during a neurodevelopmental window). This challenge is
exemplified by torsinA, a AAA+ protein that causes DYT1 dysto-
nia when its gene is mutated. The abnormal twisting movements
that characterize DYT1 dystonia emerge during a discrete period
of childhood, but mutation carriers who do not manifest dystonia
during this window typically remain symptom free for life. Deter-
mining whether there is a unique temporal requirement for
normal torsinA function during CNS development is essential
for the identification of key pathophysiological events, accurate
disease modeling, and targeted therapeutic development.3322 Cell Reports 16, 3322–3333, September 20, 2016 ª 2016 The A
This is an open access article under the CC BY-NC-ND license (http://The DYT1 mutation is a 3-bp in-frame deletion in TOR1A,
which removes a single glutamic acid residue (‘‘DE’’) from tor-
sinA (Ozelius et al., 1997). TorsinA is a membrane-associated
protein that resides within the ER/nuclear envelope (NE) endo-
membrane space. Several observations support a normal role
for torsinA at the NE that is disrupted by the DYT1 mutation.
An engineered mutation that blocks torsinA ATP hydrolysis
also causes the protein to accumulate abnormally in the perinu-
clear space (Gonzalez-Alegre and Paulson, 2004; Goodchild and
Dauer, 2004; Naismith et al., 2004). Wild-type torsinA interacts
with the NE proteins lamina-associated polypeptide 1 (LAP1),
SUN1, and several nesprins (Goodchild et al., 2005; Jungwirth
et al., 2011; Nery et al., 2008). LAP1 forms a hetero-oligomer
with torsinA and activates its enzymatic (ATPase) activity (Brown
et al., 2014; Sosa et al., 2014; Zhao et al., 2013). The DYT1
mutation impairs binding of torsinA to LAP1 and causes torsinA
to accumulate abnormally within the perinuclear space, a
phenomenon that requires SUN1 (Jungwirth et al., 2011; Nai-
smith et al., 2009; Zhao et al., 2013; Goodchild and Dauer,
2004). The relevance of these events to dystonia is supported
by the finding that a mutation in LAP1 causes a severe form of
childhood dystonia (Dorboz et al., 2014).
Mouse genetic experiments provide strong in vivo support
for a potential link between torsinA activity, nuclear membrane
function, and dystonic movements. These experiments demon-
strate that the DYT1 mutation impairs torsinA function, causing
abnormal twistingmovements and strikingmorphological abnor-
malities of the nuclear membrane selectively in post-migratory
neurons (Goodchild et al., 2005; Liang et al., 2014; Weisheit
and Dauer, 2015). These nuclear abnormalities are membranous
out-pouchings (termed ‘‘buds’’) that emerge from the inner
nuclear membrane and protrude into the perinuclear space.
The exclusive appearance of buds in neurons and their apparent
relationship to neuronal maturation are consistent with a role for
nuclear membrane dysfunction in the pathogenesis of DYT1
dystonia (Goodchild et al., 2005; Liang et al., 2014; Weisheit
and Dauer, 2015).
Structures similar to neuronal NE buds have been observed
in several developmental contexts in diverse wild-type organ-
isms (Clark, 1960; Hadek and Swift, 1962; Hochstrasser and Se-
dat, 1987a; Szo¨llo¨si, 1965; Szo¨llo¨si and Szo¨llo¨si, 1988). Someuthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
observations indicate that these buds may represent structural
intermediates of a poorly understood form of nuclear pore-
independent nucleo-cytosolic transport, a process possibly
analogous to herpesvirus nuclear egress (Maric et al., 2014). In
Drosophila, bud-like structures are implicated in the normal
transport of ‘‘mega’’ ribonucleoprotein complexes containing
Wingless signaling components (e.g., the C-terminal cleavage
product of DFrizzled-2) across the post-synaptic nuclear mem-
brane (Speese et al., 2012). Drosophila torsin protein appears
localized to the necks of these structures, and Drosophila torsin
mutants show defects in transport of mRNAs contained within
the vesicles, and related abnormalities of neuromuscular junc-
tion development (Jokhi et al., 2013).
The observation of similar nuclear membrane out-pouchings
in early developmental contexts has led to the suggestion
that this process may be required specifically when bursts of co-
ordinated protein synthesis are required to support critically
timed differentiation or maturation events (Strambio-De-Castilla,
2013). Indeed, buds in the neuronal nuclei of torsinA null (or ho-
mozygous DYT1 DE knockin) mice appear selectively in post-
migratory maturing neurons (Goodchild et al., 2005), cells highly
utilizing the machinery of mRNA synthesis and transport. Other
work links torsinA loss of function to abnormalities of nuclear
pore biogenesis and function (VanGompel et al., 2015), suggest-
ing that the dramatic increase in neuronal nuclear pore number
in maturing neurons (Lodin et al., 1978) may also contribute to
NE budding. These mechanisms imply a relationship between
bud formation and CNS maturation. It has not been possible to
explore this question directly, however, because of the perinatal
lethality of torsinA mutant mice and absence of an in vitro model
of this process (Goodchild et al., 2005; Liang et al., 2014; Tanabe
et al., 2012).
Here, we demonstrate that neuronal nuclear membrane
budding is a developmentally regulated event and identify a
molecular component of this process that controls its timing.
Neuronal NE budding in torsin mutant neurons occurs initially
following neuronal migration and peaks during a period corre-
sponding to synaptic integration and circuit formation. Remark-
ably, NE buds then disappear completely as neurons fully
mature. This developmental window is strongly modulated by
the torsinA paralog, torsinB. The developmental upregulation
of endogenous torsinB levels corresponds to the disappearance
of buds and, in mice null for both torsinA and torsinB, NE buds
develop earlier (in migrating neurons) and persist into adulthood.
We model this process in vitro during the neural specification of
DYT1mutant mouse embryonic stem cells and demonstrate that
overexpression of torsinB (or torsinA) can rescue NE bud forma-
tion. These findings link neuronal NE budding to a discrete neu-
rodevelopmental window, provide molecular insight into this
process, and have important implications for understanding
the pathogenesis of DYT1 dystonia.
RESULTS
Neuronal NE Budding Is a Cell Autonomous Process that
Occurs during a Discrete Neurodevelopmental Window
Perinatal lethality of constitutive torsinA null mice has limited our
understanding of the relationship between CNS maturation andNE budding. We reported recently that conditional deletion of
torsinA from the CNS (using nestin-Cre; ‘‘N-CKO’’ mice) is
compatible with life for up to 16 days of age (Liang et al.,
2014), enabling us to advance understanding of this question.
We first confirmed that deletion of torsinA from neural progenitor
cells (the stage of nestin-Cre expression) caused nuclear buds
indistinguishable from those previously reported in constitutive
null and DYT1 knockin mice (Goodchild et al., 2005; Tanabe
et al., 2012) (Figure 1A). To explore the relationship between
NE budding and CNS maturation, we quantified the percentage
of neurons with NE buds in several brain regions on the day of
birth (P0) and in the more mature CNS (P8). All brain regions
examined developed NE buds (Figures 1A, 1B, and S1), and
the developmental age of the brain region strongly influenced
the percentage of affected neurons observed (Figures 1B–1E).
At P0, earlier maturing caudal regions such as spinal cord and
brainstem (pons) contained a considerably higher percentage
of NE bud-bearing neurons (and NE buds/neuron) than later
maturing rostral regions, such as the striatum (Figures 1B and
1C). In all regions examined, the percentage of affected neurons
(and NE buds/neuron) increased with ongoing CNS maturation
(i.e., from P0 to P8; Figures 1B, 1D, and 1E). Additionally, the
relationship between NE buds and developmental age was
observed within brain regions containing neural classes of
differing maturational ages. For example, at P8, 80% of
earlier-born Purkinje cells (born  embryonic day, E12.5) con-
tained NE buds, whereas only 6% later-born granule cells are
affected (birthdateE13–E17; post-mitotic fromP3 onward; Fig-
ure 1B) (Machold and Fishell, 2005; Mizuhara et al., 2010).
Considered together with our previous findings, these observa-
tions indicate that NE bud formation, which begins following
neuronal migration (Goodchild et al., 2005), continues during
post-natal CNS maturation.
Little is understood about the cellular or molecular require-
ments for neuronal NE budding. To examine whether NE bud for-
mation is a neural cell autonomous process, we deleted torsinA
selectively from neurons by intercrossing floxed torsinA and
Synapsin 1-Cre transgenic mice (herein Syn-CKO mice). The
Syn-Cre transgene begins to express in maturing neurons, as
early as E12.5 (Zhu et al., 2001). Syn-CKO mice showed near
complete deletion of torsinA in the spinal cord and brainstem,
efficient deletion in cortex, and little or no deletion in cerebellum
and striatum, a pattern corresponding to transgene expression
(Figures 2A, 2B, and S2A). All regions showing efficient torsinA
deletion developed NE buds indistinguishable from those seen
in N-CKO mice (Figures 2C and S2B), demonstrating that NE
budding is a neuronal cell autonomous process.
To examine the developmental dependence of NE budding
during the complete process of neural maturation, we examined
multiple ages in the striata of Dlx5/6-Cre conditional torsinA mu-
tants that live into adulthood (herein Dlx5/6 conditional KO ‘‘Dlx-
CKO’’; Pappas et al., 2015). Additional advantages of this model
are the relative homogeneity of the striatum (95% of striatal cells
are medium spiny neurons) and the strong links between striatal
dysfunction and dystonia pathogenesis (Pappas et al., 2015; Ta-
nabe et al., 2012). These mice exhibited essentially complete
deletion of torsinA from the striatum (Figure 2D). Despite early
(E12.5) prenatal deletion of torsinA by Dlx-5/6-Cre (MonoryCell Reports 16, 3322–3333, September 20, 2016 3323
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Figure 1. Neuronal Nuclear Membrane Budding Increases
during Early Post-natal CNS Maturation
Conditional CNS deletion of torsinA caused neuronal NE buds in all
CNS regions examined.
(A) Ultrastructural images of normal control and N-CKO neuronal
nuclei with NE budding from P8 cortex (Ctx; first row). The subse-
quent rows are examples from spinal cord (SC), pons, Purkinje cells
of cerebellum (Cbl), and striatum (Str). The nuclear membrane buds
are denoted by arrows (Nucleus = N and Cytosol = C). The scale bar
represents 500 nm.
(B) Percentage of nuclei with NE buds in the CNS regions shown in
(A) at P0 and P8 (n = 2, per region/age) (Purkinje cells = PC and
granule cells = GC). The results are expressed as mean ± SEM (one-
way Anova; * = p < 0.05; ** = p < 0.01; and **** = p < 0.0001).
(C) Stacked bar graphs showing percentage of nuclei (at P0) with
different numbers of buds/nucleus by region in all regions examined.
(D and E) The number of NE buds/nucleus continues to accumulate
from P0 to P8. The stacked bar graphs show percentage of nuclei
with different numbers of buds/nucleus in pons (D) and striatum (E)
(n = 2, per region/age).
3324 Cell Reports 16, 3322–3333, September 20, 2016
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Figure 2. Neuronal Nuclear Membrane Budding Is a Cell Autonomous Process that Occurs during a Neurodevelopmental Window
(A) Western blot demonstrating efficient deletion of torsinA protein in Syn-CKOmice in cortex (Ctx), pons, and spinal cord (SC), but not striatum (Str), cerebellum
(Cbl), or liver (n = 2, per region).
(B) Quantification of the torsinA western blots displayed in (A).
(C) Percentage of nuclei with NE buds in P10 Syn-CKO mice. The results are expressed as mean ± SEM.
(D) Western blot showing efficient deletion of torsinA protein from striatum in Dlx-CKO mice.
(E) Developmental time course of NE bud frequency in striatum of Dlx-CKO mice from E18.5 to P42 reveals the trajectory of NE bud development, peak, and
resolution.
(F andG) Striatal lysates fromwild-typemice demonstrate that endogenous levels of torsinB levels are low asNEbuds accumulate (P0 to P7), and that torsinA and
torsin B exhibit opposite changes in levels of expression as NE buds resolve (P7 to P28). The levels of the torsinA-interacting proteins LAP1 and LULL1 remain
largely unchanged during this period of CNS maturation (F). The changes for torsinA, torsinB, LAP1, and LULL1 are quantified in (G) as a relative percentage to
calnexin control. The results are expressed as mean ± SEM. All lysates in duplicate for western blot.et al., 2006; Pappas et al., 2015), striatal NE buds did not begin to
appear until P3. Similar to N-CKO and Syn-CKO mice, NE
budding frequency increased during CNS maturation, reaching
a peak of35% of neurons atP7. Surprisingly, the percentageof NE bud-bearing neurons then decreased rapidly during the
second post-natal week (P7–P14) and NE buds were essentially
undetectable by P42 (Figure 2E). This disappearance of NE blebs
is not due to cell death, as striatal size and the number ofmediumCell Reports 16, 3322–3333, September 20, 2016 3325
spiny neurons are normal in Dlx-CKOmice (Pappas et al., 2015),
and assessment by TEM showed no apoptotic nuclei or other ul-
trastructural evidence of cell toxicity. Similar to Dlx-CKO mice,
analysis of older Syn-CKO mice (P23) also demonstrated com-
plete absence of NE buds (Figure S2C). These data demonstrate
that neuronal NE budding does not continue to progressively in-
crease with age as implied by findings in N-CKOmice (Figure 1B)
and in previous work (Goodchild et al., 2005; Kim et al., 2010).
Rather, NE budding is confined to a discrete neurodevelopmen-
tal window, implying the existence of factors that modulate this
process.
An intriguing candidate as a regulator of NE budding is the
torsinA paralog, torsinB. We reported previously that in vitro
torsinA and torsinB have conserved function at the NE and that
in torsinA null tissue, levels of torsinB strongly influence the
susceptibility of different cell types to the formation of NE buds
(e.g., in neuronal versus non-neuronal cells; Kim et al., 2010).
Other work demonstrates differential expression of torsinB
both spatially and temporally in mouse and human brain (Bahn
et al., 2006; Jungwirth et al., 2010; Vasudevan et al., 2006).
Therefore, we explored whether physiological changes in the
developmental expression of torsinB might correspond to the
appearance and disappearance of NE buds in Dlx-CKO mice.
Consistent with this notion, we found that in wild-type mice,
striatal torsinB levels are low during the first post-natal week
when NE buds are accumulating and then increase by more
than 3-fold during the second post-natal week coincident with
NE bud disappearance (Figures 2E–2G). TorsinA levels show
the converse pattern, decreasing after the first post-natal week
(Figures 2F and 2G). Levels of torsinA interacting proteins
LAP1 and LULL1 remain largely unchanged in this time frame
(Figures 2F and 2G). These observations implicate torsinB in
the developmental regulation of neuronal NE budding and sug-
gest a potential molecular mechanism underlying the selective
vulnerability of immature neurons to torsinA loss of function.
TorsinB Modulates the Developmental Dependence of
Neuronal NE Budding
To investigate directly a role for torsinB in neuronal NE budding,
we used gene targeting to explore the consequences of Tor1b
deletion and the effect of altering torsinB function in the context
of torsinA loss of function (Figure S3). Intercrossing germline
Tor1b+/ mice generated all expected genotypes at normal
Mendelian frequency. Tor1b/ mice were indistinguishable
from their littermate controls and showed no NE buds in the
CNS or peripheral tissues (including heart, tongue, liver, and kid-
ney; data not shown). Tor1a and Tor1b are adjacently located,
precluding the possibility of intercrossing the individual mutant
alleles to create torsinA and torsinB double null mice. We there-
fore generated a floxed allele in which the LoxP sites encompass
both Tor1a and Tor1b (Figure 3A). No germline torsinA/torsinB
double knockout mice (Tor1(ab) / or ‘‘dKO’’) were recovered
from the litters of Tor1(ab)+/ intercrosses. Assessment of prena-
tal time points demonstrated that germline dKO embryos devel-
opmentally arrest at E8.5 (data not shown). Considering the
lack of phenotype in Tor1b/ mice, this finding is consistent
with previous work indicating that torsinA and torsinB share
conserved function (Kim et al., 2010).3326 Cell Reports 16, 3322–3333, September 20, 2016To overcome the embryonic lethality of dKO mice and
examine a potential role for torsinB in modifying torsinA-related
NE budding, we used nestin-Cre to conditionally delete these
genes from neural progenitor cells (nestin double conditional
knockout, herein ‘‘N-dCKO’’; Figure 3B). N-dCKO mice were
recovered at reduced Mendelian ratios in newborn litters, but
at normal Mendelian ratios at E16.5, indicating that many die
during late gestation (Table S1). All N-dCKO mice identified in
newborn litters died in the first 12 hr of life. Standard histological
analysis (e.g., Nissl and H&E staining) of the brains of these mice
did not reveal any gross abnormalities (data not shown).
In striking contrast to the neurodevelopmental dependence
of NE buds observed in N-CKO mice (Figure 1B), essentially all
N-dCKO neurons exhibited NE buds, regardless of maturational
state (Figures 3C–3H). N-dCKO nuclei (Figure 3D) also exhibited
greater numbers of buds than N-CKO nuclei (Figure 1C). Strik-
ingly, NE budswere also observed in N-dCKOmigrating neurons
(Figures 3E–3H), a developmental stage at which NE buds are
never seen in N-CKO (data not shown) or Tor1a null orDE-torsinA
knock-in mice (Goodchild et al., 2005). This observation sug-
gests that torsinB participates in timing of initiation of NE
budding during neurodevelopment.
Todeterminewhether the later increase in torsinB levels (Figures
2F and 2G)might likewise be involved in the developmental down-
regulation of NE budding, we examined a role for this protein in
later maturing neurons. This question could not be addressed in
N-dCKO (Table S1) or Dlx-dCKO (Figure S4A) mice because of
the early lethality in these lines.We therefore utilizedmice inwhich
both torsinAand torsinBweredeletedusingSynapsin1-Cre (‘‘Syn-
dCKO’’) (Figure 4A). Syn-dCKOmice were born in normal Mende-
lian ratios and survived for up to 6 weeks (median age = 23 days;
Figure S4B). Whereas NE buds are absent by P23 in Syn-CKO
mice (Figure S2C), NE buds remain or continue to increase in all
structures examined in Syn-dCKO animals (Figures 4B and 4C).
Importantly, the early lethality of Syn-dCKOmice—in which dele-
tion is exclusively neuronal—links dysregulation of NE-budding
to neuronal dysfunction. Considered together, these data identify
torsinB asa regulator of the opening andclosing of the neurodeve-
lopmental window for NE budding in torsinA mutant mice.
A DYT1 Mutant Embryonic Stem Cell Model
Recapitulates Neurodevelopmental Onset of NE
Budding and Provides a Platform for Molecular
Therapeutics
Having established in vivo an essential role for torsinB in the clos-
ing of the NE budding window (Figure 4B), we next pursued a se-
ries of experiments to further explore the role of torsinB during
the opening of the NE budding window. Critically, we sought to
explore whether overexpression of torsinA or torsinB could
‘‘rescue’’ NE budding. In an attempt to translate our findings
into a more disease-relevant context, we pursued these studies
in the context of DE-torsinA (as exists in DYT1 dystonia sub-
jects). Neuronal NE budding of Tor1aDE/DE mice is indistinguish-
able from that of torsinA null mice, and NE buds are not observed
in Tor1a+/+ or Tor1aDE/+ littermate controls (Goodchild et al.,
2005).We therefore derivedmultiple independent mouse embry-
onic stem cell (mESC) lines from an allelic series of DE-torsinA
knock-in mice. To test whether neuronal differentiation of the
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Figure 3. TorsinB Modulates the Timing of Critical Period Opening for Neuronal NE Budding
(A) Schematic of the floxed Tor1(ab) allele and product of Cre recombination.
(B) Western blot demonstrating deletion of torsinA and torsinB from brain (Br), but not liver (Lv), in N-dCKO mice.
(C) Neurons of N-dCKO mice exhibit similarly high levels NE bud formation in areas of differing developmental age/maturational state (P0; n = 2, per region/age).
(D) Stacked bar graphs show percentage of nuclei with differing numbers of buds/nucleus by region (P0).
(E) N-dCKOmice exhibit NE budding in migrating cortical neurons, a developmental stage in which budding does not occur in N-CKOmice. The quantification of
percentage of affected nuclei (n = 2 per age) is shown.
(F–H) Ultrastructural images of migrating cortical neurons of N-dCKO animals at E16.5.
(F) Low magnification image of several migrating nuclei (N).
(G) Higher magnification of elongated migrating nuclei with NE buds.
(H) Boxed NE from (G) shows arrows pointing at NE buds at greater magnification. The scale bars represent 1 mm. The results are expressed as mean ± SEM.
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Figure 4. TorsinB Modulates the Timing of
Neurodevelopmental Window Closure for
NE Budding
(A) Western blot demonstrating conditional dele-
tion of torsinA and torsinB protein in spinal cord
(SC), pons, and cortex (Ctx) in Syn-dCKO mice.
Note that Syn-CKO expresses exclusively within
neurons, so much of the remaining protein likely
derives from non-neuronal cells.
(B) NE budding continues to increase in Syn-
dCKO neurons from P10 to P23, when it resolves
completely in Syn-CKO mice (n = 2, per region/
age) (one-way Anova; * = p < 0.05).
(C) Stacked bar graph shows percentage of nuclei
with differing numbers of buds/nucleus (P10 and
P23). Note that the NE buds/nucleus continue
to accumulate during this time. The results are
expressed as mean ± SEM.mESC clones replicates a maturation-related budding phenom-
enon selectively in neurons, we drove Tor1a+/+ and Tor1aDE/DE
mESC clones down either the neuronal or cardiomyocyte line-
ages (Figure 5A). We utilized a paradigm in which the mESC
were differentiated into embryoid bodies (EB), treated with either
retinoic acid (neural lineage) or ascorbic acid (cardiomyocyte
lineage), and subsequently plated onto an appropriate substrate
for further maturation (PDL/laminin for neurons or gelatin for
cardiomyocytes; Figure 5A). No differences in maturation were
observed between Tor1a+/+ and Tor1aDE/DE when driven down
either lineage. After 5 days of RA exposure, both genotypes
differentiated into GABAergic neurons expressing medium chain
neurofilament and GAD65/67 (Figure 5B) and developed exten-
sive neuronal processes following plating onto PDL/laminin.
Similarly, cultures of both genotypes developed foci of contract-
ing cells 2 days following ascorbic acid exposure (Movie S1).
In vivo, NE buds emerge selectively in post-migratory maturing
neurons (Goodchild et al., 2005) and increase during neuronal
maturation (Figures 1 and 2). We observed a similar pattern of
NE bud development during in vitro neuronal differentiation:
Tor1aDE/DE neuronal EBs developed NE buds that were morpho-3328 Cell Reports 16, 3322–3333, September 20, 2016logically indistinguishable from those
observed in vivo (Figure 5C), and the
percentage of affected cells increased
with neural maturation (Figure 5D; day 5
5% and day 13 60%). Similar to the
neural specificity of NE buds in vivo,
no nuclear buds were observed when
Tor1aDE/DE mESCs were driven down
the cardiomyocyte lineage (Figure 5C).
Strikingly, opposite patterns of torsinB
expression were observed in these two
lineages. TorsinB levels decreased dur-
ing neural differentiation, but increased
during cardiomyocyte differentiation (Fig-
ures 5E and 5F), establishing another
context in which levels of torsinB anti-
correlate with the formation of NE buds.
These data demonstrate that the mESCdifferentiation paradigms recapitulate fundamental attributes
of torsinA-associated NE budding seen in vivo: neuronal cell
specificity and autonomy, developmental dependence, and
anti-correlation with levels of torsinB.
Having established this in vitro platform, we tested whether
increasing levels of torsinB could suppress NE bud formation.
This experiment further tests the role of torsinB in NE bud dy-
namics and—in the context of DE-torsinA—is relevant to the
development of DYT1 therapeutics. We transduced EBs with
GFP-tagged-torsinA, -torsinB, or -torsin2-expressing lentivi-
ruses on RA-differentiation day 2, when EBs are beginning to ac-
quire neuroprogenitor characteristics (Bain et al., 1996). Both
torsinA and torsinB significantly decreased the percentage of
nuclei with NE buds (by nearly 50%). Torsin2 had no significant
effect (Figure 5G), but also appeared to potentially reduce NE
buds, raising the possibility that other torsin proteins may be
involved in this process. Transduction of EBs did not alter the
trajectory of neuronal differentiation, as all virally transduced
EBs expressed NeuN and GABA at the same rate (Figure S5A)
and to the same extent as non-transduced EBs, and transduc-
tion efficiency was similar among the different torsin isoforms
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Figure 5. TorsinB Overexpression Suppresses NE Budding during the Maturation of DYT1 Mutant Neurons
(A) Diagrammatic overview of experimental design. The wild-type and DYT1 mutant mESCs were grown in suspension for 2 days to form EBs. They were then
driven down either a neural or cardiomyocyte lineage. For the neural lineage, they were exposed to RA for 5 days and subsequently plated on poly-D-lysine (PDL)
and laminin for up to 8 days, during which time they extended processes and neuronal (N) markers. For the cardiomyocyte (CM) lineage, they were exposed to
ascorbic acid (AA) for 5 days and subsequently plated on gelatin for up to 8 days; these cultures developed beating foci within 48 hr of AA exposure.
(B) Western blots of NF-M and GAD65/67 demonstrating that control and DYT1 mutant mESCs differentiate into neurons with a similar time course following RA
exposure. g-tubulin was used as loading control.
(C) Ultrastructural analysis of mutant neurons and muscle demonstrates the development of NE buds selectively in the neural lineage that are indistinguishable
from those observed in mouse brain.
(D) Percentage of neuronal nuclei with buds increases as the cells mature on PDL/laminin (n = 2 per time point).
(E) Expression of torsinA, torsinB, LAP1, and LULL1 demonstrates a unique divergence of torsinB expression levels during neural and cardiomyocyte differ-
entiation. Note that the asterisk denotes the major immunoreactive band of LULL1 in the cardiomyocyte lysate.
(F) Relative quantification of torsinA and torsinB levels shown in (E).
(G) Introduction of lentiviral GFP-torsinA, GFP-torsinB, or GFP-torsin2A midway through neuronal differentiation. Both torsinA and torsinB rescued NE budding
phenotype in mutant neuronal EBs (Mann-Whitney: compared to vehicle, GFP-torsinA: p = 0.000094 and GFP-torsinB: p = 0.006365; p = 0.112278; ** = p < 0.01;
and **** = p < 0.0001). The results are expressed as mean ± SEM.(Figure S5B). These further support an inverse relationship
between torsinB levels and NE bud formation. Considered
together, these results establish the utility of this model system
for identifying factors that canmitigate or prevent the deleterious
effects of torsinA loss of function at the NE.DISCUSSION
Our studies establish a neurodevelopmental window for torsinA-
related NE budding during CNS maturation in vivo. These
data demonstrate that NE budding is a neurodevelopmentallyCell Reports 16, 3322–3333, September 20, 2016 3329
regulated process and describe the lethal consequences for the
organism when it is allowed to continue unabated. A regulated
role for NE budding during development is consistent with
several previous observations of NE buds in developmental
contexts (Gay, 1956; Hadek and Swift, 1962; Hochstrasser
and Sedat, 1987b; Speese et al., 2012; Szo¨llo¨si and Szo¨llo¨si,
1988). Considered together, these observations suggest that
NE budding may be a normal cellular process, and the appear-
ance of buds may reflect a stalled structural intermediate, the
progression of which is slowed or blocked by the absence of
torsinA function. The lethality that occurs when this process
is continually dysregulated—including selectively within neu-
rons—support its essential role in CNS function. We also identify
torsinB as a potent molecular modifier of torsinA-dependent NE
budding, demonstrating its ability to strongly influence both the
opening and closing of the neurodevelopmental window for
this process, and show that overexpression of torsinB can sup-
press NE bud formation in an in vitro model of DYT1 dystonia.
These findings provide a powerful platform for further elucidation
of the biological roles of NE budding during neural development
and highlight the importance of studying the developing CNS
to identify torsinA processes relevant to the pathogenesis of
dystonia.
DYT1 dystonia is30% penetrant and essentially no mutation
carriers that remain unaffected by their 20’s subsequently
develop symptoms. This pattern suggests that pathogenic
torsinA is capable of disrupting motor circuits only during an
early neurodevelopmental window. We explored this possibility
by conditionally deleting torsinA from the murine CNS and
analyzing NE budding throughout CNS maturation. Using this
approach, we identify a strong relationship between develop-
mental age and susceptibility to torsinA loss of function.
Whereas previous work implied that NE buds continue to accu-
mulate without end, we now demonstrate that NE buds disap-
pear in all mutant lines that survive into adulthood (Syn-CKO
and Dlx-CKO; Figures 2E and S2C). Considered together, these
data establish an essential requirement for torsinA function
during a neurodevelopmental window during CNS maturation.
Considerable uncertainty exists about the human age that cor-
responds to the early post-natal stage we identify as critically
dependent upon normal torsinA function. This period, however,
is likely earlier than the early childhood period when dystonic
symptoms emerge in DYT1 subjects. We propose a model
whereby early abnormalities of neural circuits consequent to
torsinA loss of function disrupt the highly dynamic develop-
mental trajectory that occurs throughout childhood, resulting in
the later emergence of dystonic symptoms. Consistent with
this model, behavioral abnormalities emerge and subsequently
worsen when NE buds have largely resolved in Dlx-CKO striatum
(Pappas et al., 2015). NE buds peak at P7, yet are largely absent
by P14 (Figure 2E). However, Dlx-CKO mice are indistinguish-
able from littermate controls until P14, when abnormal twisting
movements emerge, and progressive abnormalities on the grid
hang test do not emerge until P21, and then worsen over the
next 2–3 weeks. The concept of early deleterious events causing
symptoms to emerge much later, consequent to altered
neurodevelopmental trajectories, is well established in studies
of autism and schizophrenia, among other neurodevelopmental3330 Cell Reports 16, 3322–3333, September 20, 2016disorders (Connors et al., 2008; Hoftman and Lewis, 2011; Shaw
et al., 2010). Our current findings, previous work identifying other
torsinA loss-of-function pathologies confined to early post-natal
development (Liang et al., 2014; Pappas et al., 2015; Weisheit
and Dauer, 2015), and the clinical phenomenon of delayed-onset
dystonia (Burke et al., 1980), suggest that this model of disease
pathogenesis may also apply to DYT1 and other childhood-
onset primary dystonias.
To provide mechanistic understanding of NE budding and
identify therapeutic targets for DYT1 dystonia, we next sought
factors that modulate this neurodevelopmental window. We
and others have documented marked differences in the levels
of torsinB between neural and non-neural tissue that correlate
with susceptibility to NE bud formation (Jungwirth et al., 2010;
Kim et al., 2010). Data from rodent and human brains indicate
that levels of torsinB are low prenatally and increase substan-
tially thereafter (Bahn et al., 2006; Vasudevan et al., 2006). The
timing of increased torsinB expression presented an ideal oppor-
tunity to study the relationship of torsinB levels and NE buds in
striatum, a structure strongly implicated in dystonia. Consistent
with a potential role for torsinB in regulating NE bud dynamics,
torsinB levels remain low during the peak of NE bud formation,
but increase by 3-fold coincident with NE bud disappearance
(Figures 2F and 2G).
To directly test the role of torsinB in NE bud dynamics, we
experimentally manipulated torsinB levels in several in vivo and
in vitro contexts. In contrast to the developmental gradient
observed in N-CKO mice, nearly all N-dCKO neurons exhibited
buds, regardless of developmental age (Figures 3C and 3D).
Notably, loss of torsinB on the torsinA null background dramat-
ically lengthened the neurodevelopmental window, causing NE
buds to form in migrating neurons (Figures 3E–3H) and to persist
in mature neurons, maturational states in which NE buds are
never seen in torsinA null mice. The neurodevelopmental window
failed to close in the absence of torsinB (Figures 4B and 4C),
causing a progressive increase in NE buds and early lethality.
Importantly, Syn-CKO mice show normal viability, whereas
Syn-dCKO mice die by 6 weeks of age. Markedly earlier lethality
was also seen in all other dKOmice compared to torsinA deletion
alone, strengthening the connection between NE buds and
neuronal function. Conversely, we demonstrate that experimen-
tally increasing levels of torsinB can suppress NE bud formation
in an in vitro model of DYT1 dystonia. These data establish the
changes during CNS maturation of endogenous torsinB levels
as a physiological mechanism modulating the window of vulner-
ability to torsinA loss of function. Considered with previous work
(Kim et al., 2010; Zhao et al., 2013), it is most likely that torsinA
and torsinB share a redundant function at the NE and that a
developmental window for NE budding reflects a time when
aggregate torsin protein function (represented by the combina-
tion of torsinA and torsinB levels) dips below a critical threshold.
The ability of torsinA or torsinB to suppress NE budding in
immature neurons contrasts with our previous work (Kim et al.,
2010), demonstrating that overexpression of these proteins in-
creases NE budding in more mature primary neuronal cultures,
further highlighting a critical role for developmental timing in tor-
sin protein family function emphasized by our in vivo studies. The
finding that torsinB can effect rescue is critical, because any
therapeutic strategy based on increasing endogenous torsinA
levels will necessarily increase DYT1 mutant torsinA, which
could negate any beneficial increases from the wild-type protein
through dominant-negative effects. In contrast, modulation of
torsinB should overcome this obstacle. Considered together,
our observations demonstrate that torsinB is a potent modifier
of torsinA phenotypes and a potential therapeutic target. Future
studies will be required to determine the precise role of torsinB in
this process, whether overexpression of torsinB can suppress
NE bud formation in vivo, and if this will ameliorate the behavioral
phenotypes in torsinA mutant mice.
The discrete window during which NE buds form implicates
several developmental events as potentially related to this pro-
cess. One intriguing possibility is that torsin proteins function in
interphase nuclear pore insertion, a process that is markedly up-
regulated in maturing neurons (Lodin et al., 1978). Several yeast
strains mutant for nucleoporins develop structures similar to NE
buds (Siniossoglou et al., 1996; Wente and Blobel, 1994; Zabel
et al., 1996), and torsinA loss of function inC. elegans causes nu-
clear pore abnormalities and NE bud-like structures (VanGompel
et al., 2015), potentially linking these processes. In the striatum,
the period of NE bud formation corresponds to the time that neu-
rons are integrating into circuits, when profound changes in neu-
ral physiology occur, including the formation of projections and
synapses (Uryu et al., 1999). These events impact the NE by up-
regulating transcription—visually apparent from the transition
from hetero- to euchromatin in maturing neurons—and transla-
tion, increasing the need for nucleo-cytosolic transport to deliver
mRNAs to the cytosol. Transcription and translation are associ-
ated with an increase in nuclear pore number in interphase
cells (Doucet and Hetzer, 2010; Maul et al., 1980). In the CNS,
the number of nuclear pores increases dramatically during
cortical neuron maturation (roughly 5-fold; Lodin et al., 1978)
and following increased synaptic activity (Wittmann et al.,
2009). Synaptic activity increases nuclear membrane surface
area as well as nuclear pore number, a form of structural plas-
ticity that may reflect adaptation to a metabolically more active
state (Wittmann et al., 2009). Increasing nuclear membrane sur-
face area and related neurodevelopmental events (e.g., process
formation) require membrane synthesis. TorsinA has been linked
to lipid metabolism (Grillet et al., 2016) and several observations
in yeast demonstrate that disruption of phospolipid and related
pathways can cause NE abnormalities, some of which resemble
NE buds (Schneiter et al., 1996; Siniossoglou, 2009). Finally, a
series of observations suggests the presence of a nuclear
pore-independent form of nucleo-cytosolic transport at specific
developmental stages and at times of high metabolic demand
(Speese et al., 2012). This process appears to transport large
ribonuclear particles directly through the membrane in a manner
akin to herpesvirus budding (Speese et al., 2012), but likely
differs in important respects since herpesvirus budding pro-
ceeds normally in the absence of torsin proteins (Turner et al.,
2015). TorsinA, a membrane associated protein, may participate
in any of these processes, which are likely strongly upregulated
in maturing neurons.
Our findings fundamentally advance understanding of torsinA-
related NE budding, linking this process to a discrete neurodeve-
lopmental window, and identify the developmental expressionpattern of torsinB as a molecular mechanism governing the tem-
poral window of neural susceptibility to torsinA loss of function.
The importance of this process for dystonia pathogenesis is
supported by the presence of NE budding in LAP1 null mice
and the recent connection of LAP1 to human dystonia (Dorboz
et al., 2014). Our development of an in vitro system modeling
this phenomenon, and the demonstration that NE budding can
be rescued by torsinB, establish a powerful platform to further
dissect this biological process.
EXPERIMENTAL PROCEDURES
Mouse Breeding and Genotyping
Animal testing was conducted in accord with the NIH laboratory animal
care guidelines and with the Institutional Animal Care and Use Committee
at the University of Michigan. Prenatal birthdating of mice was determined
by the presence of a vaginal plug, designated as E0.5. For post-natal birth-
dating, the day of birth was designated as P0. Nestin-Cre, Syn-Cre, and
Dlx5/6-Cre mice were obtained from The Jackson Laboratory. Tor1a floxed
mice were described previously (Liang et al., 2014). Tor1b floxed mice were
generated by introducing LoxP sites in the Tor1b introns in between exons
2 and 3 and after exon 5 (Figure S3). Tor1(ab) floxed animals contain LoxP
sites in the Tor1a intron between exons 2 and 3 and the Tor1b intron be-
tween exons 2 and 3 (Figure 3). Both Tor1b and Tor1(ab) floxed mice are
generated by the standard method, as described previously (Liang et al.,
2014). Mouse genotyping and breeding is described in detail in Supple-
mental Information.
Generation of mESC Clones
The Tor1a+/+ and Tor1aDE/DE mESC lines were generated by superovulating
Tor1aDE/+ female mice and mating them with Tor1aDE/+ male mice. At 3.5
dpc, blastocysts were flushed from the ovaries of female mice that displayed
vaginal plugs. Blastocysts were plated on a mitomycin-C treated mouse em-
bryonic fibroblast (MEF) feeder layer. During the next 4 days blastocysts
hatched and attached to the plate. MoreMEFs were added on day 4 of plating.
The following day and every day after that, cells were fedwith fresh ESmedium
containing a Mek1/2 inhibitor (U0126; Cell Signaling Technology) until ES
colonies were observed and plentiful. At day 8 and every few days after that
the well was trypsinized and passed to another well with an established feeder
layer for each blastocyst. This was done repeatedly and the clones were
expanded to a 10-cm plate and frozen down.
mESC Culture and In Vitro Differentiation
Neural Lineage
mESCs were plated andmaintained for two passages on treated tissue culture
plates coated with 0.1% gelatin andmitotically inactivated MEF cells, followed
by two additional passages on gelatin coated plates without MEF feeders
(Millipore) in ES medium (DMEM with 4,500 mg/l glucose and 2,250 mg/l
Na-bicarbonate supplemented with 13 non-essential amino acids, 13 nucle-
osides [Specialty Media], 0.1 mM b-mercaptoethanol [Sigma], 2 mM L-gluta-
mine [Gibco], penicillin/streptomycin [Gibco], 15% FBS [HyClone], and
1,000 units/ml LIF [Chemicon]). Prior to differentiation, mESCs were trypsi-
nized, dissociated, and plated as single cells in suspension (2.0 3 106 cells
in 15 ml serum free differentiation medium). These cells were grown in aggre-
gate cultures for 2 days to form EBs in serum-free medium (Advanced DMEM/
F12 [Gibco] and Neurobasal [Gibco] media in a 1:1 ratio supplemented with
KnockOut Serum Replacement [10% by volume; Invitrogen], penicillin/strep-
tomycin [1.0% by volume; Sigma], L-glutamine (200 mM), and b-mercaptoe-
thanol [0.1 mM; [Sigma]). Following 2 days in suspension culture, EBs were
split 1:2 and treated with retinoic acid (RA; Sigma) dissolved in dimethyl-sulf-
oxide (1 mM; Sigma; 0.1% of total volume). EBs were cultured for a total of
5 days in RA-containing medium. They were then transferred to PDL/laminin
(Sigma) coated plates in non-RA containing maturation medium (Advanced
DMEM/F12 and Neurobasal media, B27 supplement [2.5% by volume; Invitro-
gen], L-glutamine [200 mM], penicillin/streptomycin [1.0% by volume]).Cell Reports 16, 3322–3333, September 20, 2016 3331
Cardiomyocyte Lineage
Following EB formation (48 hr), EBs were split 1:2 and replated in suspension
culture plates in the same media described above, except with 10% FBS and
the addition of 0.1 mg/ml ascorbic acid (Sigma). EBs were exposed to this
formulation for 5 days. EBs were then transferred to gelatin-coated tissue cul-
ture treated plates in the samemedia as used for differentiation except without
0.1 mg/ml ascorbic acid. EBs adhered to plates after 24 hr and beating foci
were detected after 48 hr.
Protein Extraction from Tissue and Cells and Western Blotting
For tissue extraction, animals were heavily anesthetized with ketamine and xy-
lazine, intraperitoneally (i.p.), and transcardially perfused with ice cold PBS.
Tissue was lysed by sonicating with 1.0% SDS lysis buffer containing
100 mM Tris-HCl (pH 8.0), 10% glycerol, 150 mM NaCl, 2 mM EDTA, and pro-
tease inhibitor cocktail (Sigma). Protein concentration was determined with
BCA assay (Pierce). Proteins were denatured prior to SDS-PAGE by boiling
with Laemmli’s sample buffer (Bio-Rad) containing b-mercaptoethanol for
5 min. After SDS-PAGE, proteins were transferred to nitrocellulose membrane,
which was blocked with blocking buffer (5.0% skim milk in PBS with 0.2%
Tween) for 1 hr at room temperature. Blocked membrane was incubated in
blocking buffer containing primary antibody overnight at 4C. Membrane
was washed with washing buffer (PBS with 0.2% Tween; PBS-T) and then
incubated in blocking buffer with HRP-conjugated secondary antibody for
1 hr at room temperature. The washed membrane was developed using
chemiluminescent substrate for HRP (Pierce) and exposed on film (Kodak
X-omat LS films or Amersham Hyperfilm). All western blots were quantified
with densitometry using ImageJ. All levels were calculated relative to calnexin
loading control.
Antibodies
The dilution rates for each antibody used in this study are listed as follows. anti-
torsinA (rabbit polyclonal; Abcam; 1:10,000); anti-torsinB (rabbit polyclonal;
kind gifts of Dr. Rose Goodchild; VIB Center for the Biology of Disease and
Dr. Christian Schlieker; Yale University; 1:1,000); anti-LAP1 and anti-LULL1
(rabbit polyclonal; kind gift of Dr. Christian Schlieker; Yale University;
1:1,000); anti-calnexin (rabbit polyclonal; Stressgen; 1:10,000); anti-GAD65/
67 (rabbit polyclonal; Millipore; 1:2,000); anti-neurofilament-M (rabbit poly-
clonal; Millipore; 1:200); g-tubulin (monoclonal; Sigma; 1:2,000); anti-NeuN
(Monoclonal A-60; Millipore; 1:200); anti-GABA (rabbit polyclonal; Sigma;
1:200); anti-GFP (rabbit polyclonal; Abcam; 1:200); Goat anti-Rabbit IgGHorse
Radish Peroxidase and Goat anti-Mouse IgG Horse Radish Peroxidase (Cell
signaling; 1:10,000); and anti-mouse Alexa Fluor 488, anti-rabbit Alexa Fluor
488, and anti-rabbit Alexa Fluor 633 (Invitrogen; 1:400).
Statistics
GraphPad Prism software (GraphPad Software) was used to analyze all data.
Means are displayed with error bars representing SEM. One-way ANOVA
tests were followed by post hoc Dunnett test, where appropriate. Mouse
survival probability was analyzed using the Kaplan and Meier method.
Analyses of NE buds quantification for the control condition of wild-type
mice is not included because we never observe NE budding in wild-type tis-
sue or cells, as initially reported (Goodchild et al., 2005), and confirmed in
extensive experiments since (Kim et al., 2010; Weisheit and Dauer, 2015).
Similarly, we never observe NE buds in wild-type ESCs driven down a neural
lineage.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, one table, and one movie and can be found with this article online
at http://dx.doi.org/10.1016/j.celrep.2016.08.044.
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